The fundamentals with Patrys are solid.
Ample cash in the bank.
Two late stage licensing deals ready to go.
Both showing exceptional safety, ideal candidates to combine with Big Pharma's current offerings. SM6 alone equals the market cap in upfront cash, add the royalties and it's many, many multiples.
The backer of the phase 2 trial is about to +$3Billion recurrent income to their books...
A network spanning both EU and US centers of excellence.
ASX Announcements like a straight pull from their scientific publications, no hype & no spin.
Solid science as displayed by their scientific publication record & an ethical investment, yet my position is due to their primed unrealized value.
The fundamentals with Patrys are solid.Ample cash in the...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $43.28K | 6.183M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 237374 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1732079 | 8 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |